EURACTIV PR

An easy way of publishing your relevant EU press releases.

Medicines for Europe

Press Releases of this organisation

TITLEsort descending ORGANISATION DATE TOPIC
Electronic product information: new report shows it is time to move from principles to action Medicines for Europe 25 Feb 2022 Health & Consumers
EMA clarifies no scientific evidence to deter use of ibuprofen to manage coronavirus symptoms Medicines for Europe 18 Mar 2020 Health & Consumers
EMA/HMA share definitive EU-wide position on biosimilar medicines interchangeability Medicines for Europe 20 Sep 2022 Health & Consumers
Energy Council (TTE) – Medicines for Europe Open letter to European Energy Ministers and responsible European Commissioners on inflation and energy costs impacting the supply of essential generic medicines Medicines for Europe 28 Sep 2022 Health & Consumers
EU can do more for equitable access to medicines Medicines for Europe 13 Jan 2023 Health & Consumers
EU can do more for patients with smart use of biosimilar medicines Medicines for Europe 29 Apr 2022 Health & Consumers
EU digital strategy requires investments in the digitalisation of Europe’s medicines regulatory agencies to succeed Medicines for Europe 15 Jan 2021 Health & Consumers
EU industrial policy can dramatically improve medicines manufacturing resilience and security of supply Medicines for Europe 17 Mar 2021 Health & Consumers
EU Industrial strategy should be key to improving medicines supply chains Medicines for Europe 17 May 2021 Health & Consumers
EU manufacturers call for urgent reforms to achieve reciprocity and a level-playing field in public procurement Medicines for Europe 30 Sep 2019 Health & Consumers
EU must address barriers to continuous off-patent innovation and grasp opportunity for patients and healthcare Medicines for Europe 23 Feb 2021 Health & Consumers
EU must learn from Covid-19 to improve crisis preparedness and response for the future Medicines for Europe 09 Nov 2021 Health & Consumers
EU must take the lead to ensure security of supply for medicines Medicines for Europe 16 Jun 2021 Health & Consumers
EU pharma strategy success depends on access to generic, biosimilar and value added medicines Medicines for Europe 25 Nov 2020 Health & Consumers
EU Pharmaceutical Strategy Roadmap: high time to improve patient access to medicines and to apply the lessons from COVID-19 Medicines for Europe 04 Jun 2020 InfoSociety
EU Semester Country Specific Recommendations: Improve patient access to medicine and ensure healthcare sustainability Medicines for Europe 24 May 2018 Health & Consumers
EU Semester Country Specific Recommendations: More Efficient Medicine Policies Needed for Patient Access Medicines for Europe 23 May 2017 Health & Consumers
European Commission launches: “What I need to know about Biosimilar Medicines - Information for patients”, in 23 EU languages Medicines for Europe 29 Nov 2017 Health & Consumers
European Commission pilot project on repurposing brings value added innovation to life Medicines for Europe 28 Oct 2021 Health & Consumers
European Health Union – first step to greater EU solidarity in health crisis situations Medicines for Europe 11 Nov 2020 Health & Consumers
European Organisation for Specialised Nurses (ESNO) launches switch management guide between similar biological medicines - a guide for nurses Medicines for Europe 26 Jun 2018 Health & Consumers
European Parliament report calls for increased use of off-patent medicines to improve patient access Medicines for Europe 25 Nov 2021 Health & Consumers
European patients need improved access to biosimilar medicines Medicines for Europe 22 Apr 2021 Health & Consumers
Europe’s life science industry urges the UK and EU27 to safeguard patients’ access to medicines with a clear transition period and a future cooperation agreement after Brexit Medicines for Europe 28 Nov 2017 Health & Consumers, UK in Europe
Failure to launch: white paper explores the role of inappropriate use of IP in blocking access to generic and biosimilar medicines Medicines for Europe 05 Nov 2020 Health & Consumers
Fulfilling the Biosimilar Promise: Report Highlights Key Principles in Support of a Sustainable Market Medicines for Europe 19 Sep 2016 Health & Consumers
Generic & biosimilar medicines pivotal for safe, effective and affordable access to medicines in Europe Medicines for Europe 28 Nov 2019 Health & Consumers
Giving medicines a new life: EU should foster patients’ access to Value Added Medicines Medicines for Europe 30 Nov 2022 Health & Consumers
Health at a Glance Report highlights public value of generic, biosimilar and value added medicines Medicines for Europe 26 Nov 2018 Health & Consumers
HERA must address outstanding weaknesses in EU pharma framework to be successful Medicines for Europe 16 Sep 2021 Health & Consumers

Pages